Hematology & Oncology Fellowship Program

The goal of the Hematology and Medical Oncology Fellowship Program is to train physician-scientists with a background in internal medicine to become independent and productive investigators. In doing so, we have designed our curriculum to meet these specific objectives.

To provide excellent clinical training in both the inpatient and outpatient arenas and to prepare the fellow to function successfully in modern health care delivery systems.
To guarantee adequate protected time for basic or clinical research.
To assist fellows in choosing an appropriate professional path.
To prepare postdoctoral fellows to pass the American Board of Internal Medicine examinations in hematology and/or medical oncology (most postdoctoral fellows prefer to be "double boarded").
To provide periodic feedback regarding performance.

The Research Component
OHSU has become one of the premier biomedical research institutions in the nation, attracting accomplished scientists from long established research centers. The ability of OHSU to garner competitive research funding substantiates the cutting edge caliber of work in progress.

Fellows within our program are mentored by faculty within the Hematology and Medical Oncology Division. Faculty members in the program are investigators in the Division of Hematology and Medical Oncology. With a low fellow-to-mentor ratio, the rewards of the research experience are optimized.

The Clinical Component
For post-doctoral fellows seeking board certification in hematology and/or medical oncology, OHSU offers an outstanding training program which complements the research aspect of the program. The clinical program includes direct care of hematology and medical oncology patients in the outpatient arena and on three separate consultation services.

The American Board of Internal Medicine requires eighteen months of clinical rotations to qualify for both Hematology and Medical Oncology Boards. This eighteen months must include a minimum of twelve months of training in the diagnosis and management of a broad spectrum of neoplastic diseases including hematologic malignancies, and the equivalent of at least six months of training in the diagnosis and management of a broad spectrum of non-neoplastic hematologic disorders. Twelve months of clinical rotations are required for one board certification. The eighteen clinical months are usually divided so that the bulk of the second and third years are dedicated to research activities. Post-doctoral fellows who elect to enter clinical practice in a non-academic setting may seek to spend additional time on clinical services and relevant electives in the third year.

University Hospital, a 509-bed facility, with a dedicated 40-bed Oncology Unit is the primary clinical environment for the Training Program. Fellows are also fully engaged with patients at the Portland Veterans Affairs Medical Center, a 438-bed hospital adjacent to OHSU, which has 25 beds dedicated to patients with hematologic malignancies or cancer. The Division of Hematology and Medical Oncology is directly affiliated with the comprehensive Hemophilia Center, the Oregon chapter of the American Red Cross, and the Oregon Cancer Center.

The Fellowship Program Director is Dr. Charles Lopez. For more information on Dr. Lopez CLICK HERE.

For more information, please email Diane Grannis, the fellowship program coordinator, at grannisd@ohsu.edu or phone the Hematology and Medical Oncology Division Office at: 503-494-8534. Beginning, application year 2007, applications will only be accepted through the ERAS program.

Our current application deadline is March 15, 2008. No late submissions will be accepted.

We require:

CAF
Medical School Transcripts
Dean's Letter
3 Letters of Recommendation
USMLE/COMLEX transcripts
ECFMG Status Report if applicable
Personal Statement

ERAS link for applications: http://www.aamc.org/students/erasfellow/about/start.htm